-
Mashup Score: 6
Commentary on: Alahmad B, Khraishah H, Royé D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, Achilleos S, Acquaotta F, Armstrong B, Bell ML, Pan SC, de Sousa Zanotti Stagliorio Coelho M, Colistro V, Dang TN, Van Dung D, De’ Donato FK, Entezari A, Guo YL, Hashizume M, Honda Y, Indermitte E, Íñiguez C, Jaakkola JJK, Kim H, Lavigne E, Lee W, Li S, Madureira J, Mayvaneh F, Orru H, Overcenco A, Ragettli MS, Ryti NRI, Saldiva PHN, Scovronick N, Seposo X, Sera F, Silva SP, Stafoggia M, Tobias A, Garshick E, Bernstein AS, Zanobetti A, Schwartz J, Gasparrini A, Koutrakis P. Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries. Circulation . 2023 Jan 3;147(1):35-46. doi: 10.1161/CIRCULATIONAHA.122.061832. Epub 2022 Dec 12. Extremes in ambient temperature are associated with excess deaths. For example, more than 60 000 excess …
Source: ebn.bmj.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 43DCRI to Partner with Novo Nordisk on Large-Scale Global Cardiovascular Study in Acute Myocardial Infarction - DCRI - 5 month(s) ago
November 11, 2023 – By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients with acute myocardial infarction. Novo Nordisk, in collaboration with the Duke Clinical Research Institute (DCRI), will initiate a global cardiovascular outcomes study called ARTEMIS. The ARTEMIS study will be conducted […]
Source: dcri.orgCategories: General Medicine News, CardiologistsTweet-
An important next step in addressing the inflammatory hypothesis in #cardiovascular disease @DCRINews to Partner with Novo Nordisk on Large-Scale Global Cardiovascular Study in Acute MI @jennifer_rymer @Drroxmehran https://t.co/7WZseLEjH0
-
-
Mashup Score: 2
There was a J-shaped association of FT4 with cardiovascular disease and mortality. Low concentrations of TSH were associated with a higher risk of all-cause mortality and cardiovascular disease mortality. The 20–40th percentiles of FT4 and the 60–80th percentiles of TSH could represent the optimal healthy ranges of thyroid function based on the risk of cardiovascular disease and mortality, with more than 5% increase of 10-year composite risk identified for FT4 greater than the 85th percentile in women and men older than 70 years.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
The optimal healthy ranges of #thyroid function defined by the risk of #cardiovascular disease and mortality: systematic review and individual participant data meta-analysis https://t.co/ml2Gfq4B3N #CVD
-
-
Mashup Score: 0FDA clears next-gen image-guided therapy tech from GE HealthCare - 6 month(s) ago
GE HealthCare announced today that the FDA granted 510(k) clearance to its Allia IGS Pulse system.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA clears next-gen #imageguidedtherapy #IGT tech from @GEHealthCare | #cardiovascular https://t.co/mgBBK2HqAb https://t.co/F2a9zbr8hx
-
-
Mashup Score: 0What's next for Abbott's cardiovascular business? - 6 month(s) ago
Abbott boosted its vascular device offerings even more with its acquisition of Cardiovascular Systems. Find out more at DeviceTalks West.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
What’s next for @AbbottCardio #cardiovascular business? | #medicaldevices https://t.co/NI3CM6mn6W
-
-
Mashup Score: 1Arineta announces SpotLight Duo - 6 month(s) ago
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners. The two products extend Arineta’s leadership as the only dedicated cardiovascular CT system, and the Duo system adds high resolution thoracic clinical capability, including for lung cancer, COVID19, and other pulmonary diseases. Both the SpotLight and SpotLight Duo systems add extended coverage for peripheral vascular and runoff studies, a rapidly growing procedure for vascular therapies. “Arineta has been the leader in cardiovascular CT technology, and the new SpotLight systems continue Arineta’s history of clinical innovation,” said Scott Schubert, Arineta CEO. “Our vision is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease- the number one cause of death and costs for healthcare worldwide.” “The recent change in guidelines from the ACC
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ArinetaCardio #Arineta #CardiacImaging announced the #FDA 510(k) clearance of the #SpotLight and #SpotLightDuo family of #cardiovascular #CT (#CCT) scanners: https://t.co/Qj3RE4Th7Z
-
-
Mashup Score: 2
ACC is dedicated to creating a strong, diverse and inclusive pipeline of future cardiovascular physicians and scientists. ACC’s Internal Medicine Cardiology Programs are designed to introduce participants to a career in cardiology by connecting them with the mentors, peer network and resources they need to understand career opportunities in the field of cardiology.
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
It’s Launch Day 🚀 for the newest Hispanic/Latinx cohort of the #ACCIMProgram! Please join us in congratulating our participants️ and tell us ⬇️ why you’re interested in #cardiovascular care! Learn more about the program 👉 https://t.co/PME0triE36 #ACCDiversity https://t.co/IopBhbrrC9
-
-
Mashup Score: 0
HONOLULU — Young patients with obstructive sleep apnea faced heightened odds for major adverse cardiovascular and cerebrovascular events if they abused drugs, according to an abstract presented at the CHEST Annual Meeting.“Early screening of substance abuse in young OSA patients may reduce the risk of major adverse cardiovascular and cerebrovascular events (MACCE),” Laxman
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #CHEST2023: Young patients with obstructive sleep apnea (#OSA) 😴 faced heightened odds for major adverse #cardiovascular ❤️ and #cerebrovascular 🧠 events if they abused drugs. @CardiologyToday https://t.co/dfYEp0q83c
-
-
Mashup Score: 5Cardiovascular Manifestations and Management in ADPKD - 7 month(s) ago
Cardiovascular disease (CVD) is the major cause of mortality in autosomal dominant polycystic kidney disease (ADPKD) and contributes to significant bu…
Source: www.sciencedirect.comCategories: Latest Headlines, NephrologyTweet-
RT @KIReports: #Cardiovascular Manifestations and Management in #ADPKD https://t.co/DE4MZxkW1E #KIRReview https://t.co/cb55skB0HY
-
-
Mashup Score: 1SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - 7 month(s) ago
Nature Cardiovascular Research – Eberhardt et al. show that SARS-CoV-2 infects human coronary lesions where it preferentially targets plaque macrophages, triggering plaque inflammation and…
Source: www.nature.comCategories: Latest Headlines, RheumatologyTweet-
#SARSCoV2 replicates in macrophages within coronaries of patients who died from severe #COVID19 ➡️Mechanistic link between infection of atherosclerotic coronary vessels & acute #cardiovascular complications of #COVID 👉🏽https://t.co/fZE43hfDn7 via @NatureCVR https://t.co/0tXylaB3ym
-
🔥🌡️ Stay aware, nurses! Extreme temperatures, be it hot or cold, are linked to higher #cardiovascular mortality rates. Check out this hot off the press commentary article by @barrett1972 👀🔍 Read it here 🔗 https://t.co/3RwYFYP0jf https://t.co/yQQ6XTRspx